Share Name Share Symbol Market Type Share ISIN Share Description
Eden LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.65p -6.07% 10.05p 9.60p 10.50p 10.65p 10.00p 10.65p 31,324 08:26:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.9 -0.8 -0.3 - 20.82

Eden Share Discussion Threads

Showing 5001 to 5023 of 5025 messages
Chat Pages: 201  200  199  198  197  196  195  194  193  192  191  190  Older
DateSubjectAuthorDiscuss
24/9/2018
09:10
https://www.bbc.co.uk/news/av/business-45605018/will-organic-revolution-boost-farming-in-india I had a teacher at school who used to go on about the importance of the soil and all things organic. I thought he was a bit eccentric in his views, but not any more. I try to get all my family's veg organic now, and I think the trickle of concern around what we're putting into our food and taking out of our soil will only grow. Therefore interesting to see that even in a poor economy such as the one above, organic farming can be seen as value accretive, not just in terms of improving one of the most important things we have - our soil. Wan, interested to have your take on these results. You've homed in sales. This still looks like a long game, and too long for many. But at this stage, sales are indeed a significant way of valuing such companies, in the absence, yet of any significant profit.
brucie5
24/9/2018
08:36
Sorry to be a wet blanket BUT still very much a jam tomorrow company - Cash burning and (imo) likely to need further funding - but at what price? Market cap (assuming ADVFN right at approx £20M) and possible annualised cash burn of £2M Been watching sector and coy for many years but no incentive at this stage to buy. OK - Why am I wrong (if any thinks I am) and if so target price!! Have a great week -
pugugly
24/9/2018
07:56
A 58% increase in product sales is very encouraging with more to come in the second half. Announcements in the coming weeks (as opposed to months) regarding Terpene Tech should provide further guidance and interest. There appears to be plenty of news flow potential regarding other opportunities over the next 6 months, with 2019 providing a number of step changes.
wan
24/9/2018
07:47
It shows sales growing by over 50%... going in the right direction...
bjlk
24/9/2018
07:46
Mevalone up 58% but not by as much as we had hoped but 'further sales gains are expected as we expand the "label" for Mevalone to include major new disease and crop targets'. Good % Repeat orders. No Short order Dates for Bayer Animal products. TT Deodorant is Where exactly? Good 'coming weeks' news on Headlice Treatment into 'UK Discount retail market' with Europe to follow. Finances £2.6m in the bank / Cash burn a little under £1.1m No further concrete news on Pipeline Animal Health and Consumer Health Verticals except TT Headlice which is now Sans Deodorant so Supersonico Bayer/TT strategy still in play. Sustaine? where are you
supersonico
24/9/2018
07:13
Results are out. Nothing to get excited about. TT launch delayed again till the end of the year. Super, Sadly market knew better. Share price did tell us what there was to know.
northwick
23/9/2018
18:34
Hello SuperLooks like Mrs100k has been on a sabbatical. Is she likely to jump and and add to to holding tomorrow? What would she be looking out for in the account tomorrow, hoping they are out tomorrow? What would convince her to indulge again?
northwick
22/9/2018
11:24
Good read wan.
littlealbatross2
22/9/2018
09:24
Further down is an abstract of a presentation from Eastman for Cedroz at the 33th Symposium of the European Society of Nematologists Ghent, 9 – 13th September 2018, where Bayer and Syngenta were the main sponsors. Plenary session Integrated nematode control solutions are a must in the future Jaap Smedema Bayer AG, CropScience Division, Strategic Business Management, Alfred-Nobel-Str.50, 40789 Monheim am Rhein, Germany. jaap.smedema@bayer.com Plant-parasitic nematodes are considered to cause an estimated financial loss of over 80 billion EUR per year. Thus, nematode management in agricultural crops is necessary to prevent severe yield losses. However, nematode management is challenging since effective solutions are becoming rare due to regulatory concerns and shrinking societal acceptance of available chemical control products. The complexity of both, the nematode pest and current growing systems, make efficient nematode management even more challenging. Grower’s dilemma cannot be overcome by one technology alone. Instead, it requires an integrated set of measures that will help mitigating the impact of nematodes throughout the growing season. This integrated approach could comprise the use of good agricultural practices, cover crops, solarization, resilient varieties, analytical tools and finally the combination of chemical and biological control products. The success of such an approach has already been demonstrated in vegetable crops. Nevertheless, substantial implementation of this concept requires a holistic view and close collaboration of scientists, suppliers and most importantly, the grower to adapt the toolbox to the diverse local conditions and agricultural practices. CEDROZ®, a new terpene nematicide against root knot nematode on Solanaceae and cucurbits Emanuele Medico, Eva Van Hende, Khalid El Quadi and Maria De Las Mercedes 1Eastman Chemical B.V. - Eastman European Technology Center, Technologiepark 21, 9052 Zwijnaarde, Belgium. emanuele.medico@eastman.com The new product (Cedroz®) is an innovative suspension of capsules (CS) based on thymol and geraniol, better known as terpenes. These terpenes have a nematicidal action identified, developed and tested by Eden Research plc and Eastman Chemical B.V. Thymol and geraniol are phenols and alcohols, respectively, with the characteristic of being volatile, lipophilic and insoluble in water. Thanks to the innovative formulation of capsules that promotes suspensibility without the use of solvents, these terpenes can be dissolved in solution and applied to the soil with a slow and gradual release. The mode of action of thymol and geraniol is explained by their synergistic interaction on the lipid substances contained in the cell membranes of nematodes and their eggs. In experimental tests on Solanaceae plants and cucurbits, Cedroz showed an efficacy level comparable to that of the existing post-transplant control solutions. Thymol and geraniol have a favourable toxicological, ecotoxicological and environmental profile. The commercial product will not have pre-harvest interval and will be exempt from LMR. Page 13 - https://tinyurl.com/ESN-Abstract-Book I assume that LMR in the final sentence is a typo and should be MRL (Maximum Residue Levels). In short, no need to wait for a safety interval post application and prior to harvest as there are no harmful residues, which is a big deal as indeed highlighted in the opening comments from Bayer!
wan
21/9/2018
09:57
Eden Tweeting on acceleration of French Biocontrol with French Minister STEPHANE TRAVERT and Sumi Agro. hTTps://twitter.com/edenresearch hTTps://twitter.com/StTRAVERT
supersonico
20/9/2018
17:02
LOL Super. Put Max Bygraves on the turntable......Altogether now, "Tulips from Amster...
littlealbatross2
20/9/2018
16:30
They still might be none the wiser next week. 'Yet' is a short order / Coming months word. eg.. Supersonico.. "are we there yet mum I want to see that idiot Farmer Tom"? Mum... "not long Super my darling" or in Dutch Supersonico.. "are we there yet Lykele van der Broek, former COO of Bayer Crop Science and former Head of the Animal Health division of Bayer Health Care? I want to see that idiot Farmer Tom Lykele.. "in short order Super my lieve tulp"
supersonico
20/9/2018
16:23
Confident reply, Super.I hope you are proved right next week. All the private shareholders I know are holding their breaths.
northwick
20/9/2018
14:45
The Market knows nothing. yet
supersonico
20/9/2018
14:38
None as evidenced by current poor share price. Market knows best
northwick
20/9/2018
14:03
What is the lykelehood of good news in the upcommimg Results?
littlealbatross2
20/9/2018
08:37
A pesticide market 122 times bigger than bio! So right now, not enough revenue for multiple bio participants alone, but a huge opportunity for co-encapsulation to reduce MRL's to a less toxic state. And for novel delivery methods where encapsulation, not necessarily co-encapsulation, would be beneficial. This of course creates some time for NPD on the bio product side.That said we know how long it takes to research, develop, field trial, have approved and fund such products. Sustaine can help circumvent some of that or delay such a requirement by co-encapsulation which may speed things up to a satisfactory state at regulatory level. This is why I see big Agro-chemical companies potentially lining up for Sustaine either under rights or purchasing outright, potentially leaving Eden as a bio product R and D house, if they are to remain.
investingisatrickygame
20/9/2018
07:44
An interesting read - The Opportunity for External Innovation and Science Advancement in Animal Health SEPTEMBER 18, 2018 MICHAEL HELMSTETTER Editor’s Note: Michael Helmstetter is co-founder, president, and CEO of Technology Acceleration Partners (TechAccel), the venture development organization focused on the agriculture industry. The organization focuses on accelerating tech, by bringing private capital, deal expertise and scientific expertise to the table with a network of affiliated universities and agribusinesses. Recently it partnered with Reliance Animal Health Partners to launch Covenant Animal Health Partners, which is dedicated to the development and registration of “revenue-ready” animal health products. We asked Helmstetter to describe the partnership and rationale for its launch. In the animal health ecosystem, the industry is made up of a handful of giants and, at the far end of the spectrum, a host of smaller emerging companies and startups. There’s not much in the middle. The giants, built by mergers and acquisitions and consolidations, in recent years have been mostly internally focused on achieving economies of scale and reducing redundancies in resources and products. The smaller players have been challenged to attract capital to achieve the growth ambitions plotted in their business plans. This fragmentation of the ecosystem, the internal focus of the major players, and the lack of ready capital for smaller ventures exposes a bit of uncertainty in this industry. And all this at a time when biotechnology, genetics tools, and big data analytics are driving a golden age of innovation. But, as Albert Einstein famously said, “In the middle of difficulty lies opportunity.” I have to agree. As the founder of a technology and venture development organization, I’ve seen plenty of viable innovations ripe for entering the animal health market. Sources include university research centers, startups, entrepreneurs, major animal health firms and of course, human health pharma and medical products that have – or could have – application in animal markets. That’s why my company, TechAccel, just launched a new subsidiary called Covenant Animal Health Partners. This new partnership takes aim at the current state of the ecosystem, and targets a way to help the players – large and small – grow. The opportunities in the animal health market span the landscape: alternatives to antibiotics, vaccines, novel delivery methods, new therapeutics, data- and internet-driven applications, nutrient systems and more. For antibiotics and antimicrobials alone, the market shows strong growth and is estimated to reach $4.7 billion within two years. Full story, Agfunder - https://tinyurl.com/Animal-Health-Opportunity
wan
20/9/2018
07:14
hTTps://www.copa-cogeca.eu/Menu.aspx 11/09/2018 Biocontrol solutions in the limelight - Copa-Cogeca and IBMA publish their new Roadmap for collaboration on biocontrol solutions hTTp://www.europarl.europa.eu/cmsdata/150088/Statement_Copa-Cogeca_Pesonen.pdf hTTp://www.hortidaily.com/article/45736/Roadmap-for-collaboration-on-biocontrol-solutions During his presentation David Cary, IBMA’s executive director “recognises and values working closely with farmers through Copa and Cogeca. Both organisations see these low-risk biological plant protection products as the key to the farming of the future. This is increasingly being recognised across society and the partnership is pivotal to this happening, as is the work within the European Parliament on low-risk biological Plant Protection Products.”
supersonico
19/9/2018
16:30
Not right now but they're playing a longer game and will make a heap of cash out of Eden...and so will I along with those others who are making you laugh.
supersonico
19/9/2018
16:17
Hmmm !Remember I managed to get out at a big loss at 14.5p not a whopping loss. Do you think the investment committee at Livingbridge are ecstatic with their investment right now ?
quazie12
19/9/2018
13:29
Q12 If the other thread has given you a laugh I'm happy because at least your not grumpy. It also means that if you read my posts on what I think will happen to TT then you'll be in hysterics which is good because I also do like to make people Laugh, especially grumpy folk like yourself who find it difficult to smile.
supersonico
19/9/2018
13:25
Btw, How is our stunning investment in Terpenetech and head lice treatment doing ? I guess we'll find out in the next 12 weeks :)
investingisatrickygame
Chat Pages: 201  200  199  198  197  196  195  194  193  192  191  190  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180924 09:19:57